Skip to main content

Youth

What's new

A remote six-month clinical trial is recruiting 150 children between the ages of two to five whose families are interested in trying automated insulin delivery. The study will evaluate the use of automated insulin delivery in young children to see if it improves Time in Range and other health metrics. Continue Reading »

The latest innovations in diabetes technology have brought Time in Range (TIR) to the forefront of diabetes care. Read to learn about the most exciting TIR news from one of the biggest international diabetes conferences of the year, with a special focus on automated insulin delivery systems for kids, adults, and seniors. Continue Reading »

Provention Bio’s new injectable drug was recommended by an FDA committee for approval on May 25, 2021. Studies show that Teplizumab can delay, for people at risk for type 1, the onset of the condition for two years or more. Learn what happened at the FDA meeting and what might come next. Continue Reading »

The diaTribe team covers the latest in diabetes technology from the 14th annual ATTD 2021 international conference (set virtually this year). Here are our top highlights from day one – stay tuned for updates on the rest of the conference! Continue Reading »

The Your SAY: Hypoglycemia study is a 30-minute online survey that will help an international research team understand how severe low blood sugar affects quality of life – for people around the world living with type 1 diabetes, type 2 diabetes, and their loved ones. Continue Reading »

When can people with diabetes feel normal again following the COVID-19 crisis? When can we stop wearing masks, start seeing friends and family, and comfortably send kids to school? Continue Reading »

This clinical trial is currently recruiting. Families will participate in weekly sessions that focus on topics related to diabetes distress and parent-teen communication, with the hopes of improving Time in Range and lowering A1C levels in the teen with type 1 diabetes.  Continue Reading »

The American Diabetes Association has lowered the A1C target for children to less than 7.0%, aiming to improve long-term health outcomes without increasing hypoglycemic events. Continue Reading »

Pages